Abiopharma

🔍 Lanigan Mark W. (Director)

Company: MALIBU BOATS, INC. (MBUU)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 780 shares of Class A Common Stock at $25.92 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 84,523.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Pursuant to the Issuer's Directors' Compensation Policy (the "Policy"), directors may elect that their cash annual retainer be converted into either fully vested (i) shares of the Issuer's Class A Common Stock or (ii) rights to receive an award of stock units that will be paid on a deferred basis. In accordance with the reporting person's election, the reporting person was issued 780 stock units for the portion of the annual retainer earned for the quarterly period ended March 31, 2026.
• F2: The stock units are fully vested and payable in an equivalent number of shares of the Issuer's Class A Common Stock upon the first to occur of (A) the date of the reporting person's separation from service, (B) the occurrence of a change in control under the Issuer's Long-Term Incentive Plan or (C) an in-service distribution date elected by the reporting person (each, a "Payment Event"). The reporting person may elect whether amounts becoming payable shall be paid in a lump-sum within 30 days following the Payment Event, or in annual installments over a period of 5 years or 10 years.
• F3: Includes 18,049 stock units with vesting terms described in footnote 2 and 46,474 stock units that are fully vested and payable in an equivalent number of shares of the Issuer's Class A Common Stock upon or as soon as practicable, and in all events within 30 days, following the first to occur of (A) the date of the reporting person's separation from service or (B) the occurrence of a change in control under the Issuer's equity incentive plans.